Objectionable microorganisms in pharmaceutical production: Validation of a decision tree

Area of Science:

• Pharmaceutical Microbiology
• Drug Safety Evaluation

Background:

• Non-sterile drug manufacturing requires controlling microbial contamination to ensure product quality, safety, and efficacy.
• Objectionable microorganisms can lead to product degradation, indicate poor manufacturing hygiene, or pose risks to patient health.

Purpose of the Study:

• To develop an objective and verifiable method for evaluating objectionable microorganisms in non-sterile drugs.
• To create a decision tree and data collection template to standardize microbial risk assessment.

Main Methods:

• A decision tree was developed for evaluating microorganisms.
• Hypothetical scenarios combined 24 biological agents (harmless and pathogenic) with 9 non-sterile drug product types representing different administration routes.
• Data collection templates were utilized for objective evaluation.

Main Results:

• The decision tree approach facilitated easy and verifiable microbial evaluations.
• The study demonstrated that microorganisms not previously considered objectionable could pose a risk.
• The method effectively distinguished between acceptable and objectionable microbial contamination for various drug products.

Conclusions:

• The developed decision tree provides a robust framework for assessing objectionable microorganisms in non-sterile drug products.
• This standardized approach enhances the reliability and objectivity of microbial quality control in pharmaceutical manufacturing.
• Even seemingly harmless microbes require careful evaluation to ensure patient safety.